Stock Scorecard



Stock Summary for MediWound Ltd (MDWD) - $18.75 as of 8/13/2025 8:59:47 PM EST

Total Score

9 out of 30

Safety Score

25 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for MDWD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MDWD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MDWD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MDWD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MDWD (25 out of 100)

Stock Price Rating (Max of 10) 6
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 4
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 3
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for MDWD

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers - MediWound ( NASDAQ:MDWD ) 8/13/2025 12:45:00 PM
MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers 8/13/2025 12:45:00 PM
Nektar Therapeutics ( NKTR ) Reports Q2 Loss, Tops Revenue Estimates 8/7/2025 9:30:00 PM
Stevanato Group ( STVN ) Q2 Earnings and Revenues Beat Estimates 8/5/2025 11:40:00 AM
MediWound to Report Second Quarter 2025 Financial Results 8/4/2025 11:30:00 AM
MediWound to Report Second Quarter 2025 Financial Results - MediWound ( NASDAQ:MDWD ) 8/4/2025 11:30:00 AM
Vericel Reports Second Quarter 2025 Financial Results 7/31/2025 12:08:00 PM
Here's What Could Help MediWound ( MDWD ) Maintain Its Recent Price Strength 7/24/2025 12:50:00 PM
Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday - Becton Dickinson ( NYSE:BDX ) , Accenture ( NYSE:ACN ) 5/22/2025 1:21:00 PM
MediWound ( MDWD ) Q1 2025 Earnings Call Transcript 5/21/2025 4:36:00 PM

Financial Details for MDWD

Company Overview

Ticker MDWD
Company Name MediWound Ltd
Country USA
Description MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
Sector Name LIFE SCIENCES
Industry Name MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Most Recent Quarter 3/31/2025
Next Earnings Date 8/12/2025

Stock Price History

Last Day Price 18.75
Price 4 Years Ago 16.52
Last Day Price Updated 8/13/2025 8:59:47 PM EST
Last Day Volume 52,632
Average Daily Volume 59,645
52-Week High 22.50
52-Week Low 14.14
Last Price to 52 Week Low 32.60%

Valuation Measures

Trailing PE N/A
Industry PE 15.88
Sector PE 57.42
5-Year Average PE -60.82
Free Cash Flow Ratio 22.06
Industry Free Cash Flow Ratio 19.00
Sector Free Cash Flow Ratio 30.31
Current Ratio Most Recent Quarter 2.15
Total Cash Per Share 0.85
Book Value Per Share Most Recent Quarter 2.90
Price to Book Ratio 6.44
Industry Price to Book Ratio 1.11
Sector Price to Book Ratio 28.40
Price to Sales Ratio Twelve Trailing Months 10.48
Industry Price to Sales Ratio Twelve Trailing Months 1.97
Sector Price to Sales Ratio Twelve Trailing Months 32.19
Analyst Buy Ratings 4
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 10,807,700
Market Capitalization 202,644,375
Institutional Ownership 43.20%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -350.03%
Reported EPS 12 Trailing Months -2.05
Reported EPS Past Year -0.07
Reported EPS Prior Year -3.07
Net Income Twelve Trailing Months -21,221,000
Net Income Past Year -30,224,000
Net Income Prior Year -6,716,000
Quarterly Revenue Growth YOY -20.30%
5-Year Revenue Growth -8.65%
Operating Margin Twelve Trailing Months -132.10%

Balance Sheet

Total Cash Most Recent Quarter 9,155,000
Total Cash Past Year 9,155,000
Total Cash Prior Year 11,866,000
Net Cash Position Most Recent Quarter 9,155,000
Net Cash Position Past Year 9,155,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 31,153,000
Total Stockholder Equity Prior Year 31,595,000
Total Stockholder Equity Most Recent Quarter 31,272,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -19,099,000
Free Cash Flow Per Share Twelve Trailing Months -1.77
Free Cash Flow Past Year -19,897,000
Free Cash Flow Prior Year -16,929,000

Options

Put/Call Ratio 0.57
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.42
MACD Signal -0.26
20-Day Bollinger Lower Band 15.56
20-Day Bollinger Middle Band 19.03
20-Day Bollinger Upper Band 22.49
Beta 0.22
RSI 42.37
50-Day SMA 18.10
150-Day SMA 14.21
200-Day SMA 14.54

System

Modified 8/12/2025 4:50:09 AM EST